Cortical Stimulators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Cortical Stimulators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Cortical Stimulators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Cortical Stimulators pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.The cortical stimulator is a medical device used to revive neural activity in the nervous system of critical patients by delivering an electrical shock using leads and electrode arrays implanted on the surface of the brain to induce brain activity.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cortical Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cortical Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cortical Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

  • 2 Table of Contents
    1 About GlobalData
    2 Table of Contents
    2.1 List of Tables
    2.2 List of Figures
    3 Introduction
    3.1 Cortical Stimulators Overview
    4 Products under Development
    4.1 Cortical Stimulators - Pipeline Products by Stage of Development
    4.2 Cortical Stimulators - Pipeline Products by Territory
    4.3 Cortical Stimulators - Pipeline Products by Regulatory Path
    4.4 Cortical Stimulators - Pipeline Products by Estimated Approval Date
    4.5 Cortical Stimulators - Ongoing Clinical Trials
    5 Cortical Stimulators - Pipeline Products under Development by Companies
    5.1 Cortical Stimulators Companies - Pipeline Products by Stage of Development
    5.2 Cortical Stimulators - Pipeline Products by Stage of Development
    6 Cortical Stimulators Companies and Product Overview
    6.1 ab medica spa Company Overview
    6.1.1 ab medica spa Pipeline Products & Ongoing Clinical Trials Overview
    6.2 Aleva Neurotherapeutics SA Company Overview
    6.2.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
    6.3 Cadence Neuroscience Inc Company Overview
    6.3.1 Cadence Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.4 Catalan Institute of Nanoscience and Nanotechnology Company Overview
    6.4.1 Catalan Institute of Nanoscience and Nanotechnology Pipeline Products & Ongoing Clinical Trials Overview
    6.5 Cerephex Corporation Company Overview
    6.5.1 Cerephex Corporation Pipeline Products & Ongoing Clinical Trials Overview
    6.6 Cerevast Therapeutics Inc Company Overview
    6.6.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.7 Cognito Therapeutics Inc Company Overview
    6.7.1 Cognito Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.8 Cortivis Company Overview
    6.8.1 Cortivis Pipeline Products & Ongoing Clinical Trials Overview
    6.9 Iowa State University Company Overview
    6.9.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview
    6.10 King's College London Company Overview
    6.10.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview
    6.11 Koninklijke Philips NV Company Overview
    6.11.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview
    6.12 Lawrence Livermore National Laboratory Company Overview
    6.12.1 Lawrence Livermore National Laboratory Pipeline Products & Ongoing Clinical Trials Overview
    6.13 Neuronix Ltd Company Overview
    6.13.1 Neuronix Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.14 Nexstim Plc Company Overview
    6.14.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview
    6.15 NYU Langone Health System Company Overview
    6.15.1 NYU Langone Health System Pipeline Products & Ongoing Clinical Trials Overview
    6.16 Polytechnique Montreal Company Overview
    6.16.1 Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview
    6.17 Precisis AG Company Overview
    6.17.1 Precisis AG Pipeline Products & Ongoing Clinical Trials Overview
    6.18 Ripple Company Overview
    6.18.1 Ripple Pipeline Products & Ongoing Clinical Trials Overview
    6.19 St. Jude Medical LLC Company Overview
    6.19.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
    6.20 University of Wisconsin Madison Company Overview
    6.20.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
    6.21 WISE s.r.l. Company Overview
    6.21.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
    7
    8 Cortical Stimulators- Recent Developments
    8.1 May 04, 2023: Cardinal Health reports third quarter fiscal year 2023 results and raises fiscal year 2023 non-gaap eps guidance
    8.2 Apr 27, 2023: Zynex announces 2023 first quarter earnings
    8.3 Apr 19, 2023: Zynex to announce first quarter 2023 financial results
    8.4 Mar 31, 2023: Nexstim Resolutions of the Annual General Meeting of Shareholders
    8.5 Mar 13, 2023: Zynex Announces 2022 Fourth Quarter and Full Year Earnings
    8.6 Mar 10, 2023: Nexstim Invitation to the Annual General Meeting
    8.7 Mar 10, 2023: Zynex Reschedules Release of Fourth Quarter and Full Year 2022 Financial Results
    8.8 Mar 06, 2023: Zynex to Postpone Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call
    8.9 Feb 27, 2023: Nexstim Announces Financial Results January–December 2022
    8.10 Feb 02, 2023: Cardinal Health Reports Second Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance
    8.11 Dec 19, 2022: Cardinal Health Names Aaron Alt Chief Financial Officer
    8.12 Dec 17, 2022: Nexstim announces Changes in the management team
    8.13 Oct 27, 2022: Zynex Announces 2022 Third Quarter Earnings
    8.14 Sep 08, 2022: Cardinal Health Announces Pharmaceutical Segment Organizational Changes
    8.15 Sep 01, 2022: Zynex Medical to Participate in H.C. Wainwright Annual Global Investment Conference
    8.16 Aug 12, 2022: Nexstim Announces Half-year Report January 1 - June 30, 2022 (Unaudited)
    8.17 Aug 11, 2022: Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022
    8.18 Aug 01, 2022: Cardinal Health Names Michelle Greene as Chief Information Officer
    8.19 Jul 28, 2022: Zynex Announces 2022 Second Quarter Earnings
    8.20 Jul 11, 2022: Zynex Reports Preliminary Second Quarter 2022 Results and Reiterates Full Year Revenue and Ebitda Guidance
    8.21 Jul 07, 2022: Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2022 on August 11
    8.22 May 30, 2022: Nexstim to Present at Redeye Growth Day 2022
    9 Appendix
    9.1 Methodology
    9.2 About GlobalData
    9.3 Contact Us
    9.4 Disclaimer
    2.1 List of Tables
    Table 1: Cortical Stimulators - Pipeline Products by Stage of Development
    Table 2: Cortical Stimulators - Pipeline Products by Territory
    Table 3: Cortical Stimulators - Pipeline Products by Regulatory Path
    Table 4: Cortical Stimulators - Pipeline Products by Estimated Approval Date
    Table 5: Cortical Stimulators - Ongoing Clinical Trials
    Table 6: Cortical Stimulators Companies - Pipeline Products by Stage of Development
    Table 7: Cortical Stimulators - Pipeline Products by Stage of Development
    Table 8: ab medica spa Pipeline Products & Ongoing Clinical Trials Overview
    Table 9: Cyberbrain - Product Status
    Table 10: Cyberbrain - Product Description
    Table 11: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
    Table 12: cortiSTIM - Product Status
    Table 13: cortiSTIM - Product Description
    Table 14: Cadence Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 15: Next Generation Implantable Device - Epilepsy - Product Status
    Table 16: Next Generation Implantable Device - Epilepsy - Product Description
    Table 17: Catalan Institute of Nanoscience and Nanotechnology Pipeline Products & Ongoing Clinical Trials Overview
    Table 18: Neuroprosthetic Cortical Device - Product Status
    Table 19: Neuroprosthetic Cortical Device - Product Description
    Table 20: Cerephex Corporation Pipeline Products & Ongoing Clinical Trials Overview
    Table 21: NeuroPoint - Product Status
    Table 22: NeuroPoint - Product Description
    Table 23: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 24: Pulsed Transdermal Electrical Stimulation Device - Migraine - Product Status
    Table 25: Pulsed Transdermal Electrical Stimulation Device - Migraine - Product Description
    Table 26: Cognito Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 27: CogTx-001 - Product Status
    Table 28: CogTx-001 - Product Description
    Table 29: Cognito Therapeutics Inc - Ongoing Clinical Trials Overview
    Table 30: CogTx-001 - A Randomized, Double-blind, Sham-controlled, Adaptive- Design Pivotal Study of Sensory Stimulation in Subjects with Alzheimer's Disease (Hope Study, CA-0011)
    Table 31: CogTx-001 - Multi-center Study of Sensory Stimulation to Improve Brain Function: Overture Study
    Table 32: CogTx-001 - Multi-Center Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
    Table 33: CogTx-001 - Sensory-Evoked Cortical Gamma Oscillation: Impact on Visual Processing and Cognitive Function in Patients with Alzheimer's Disease
    Table 34: Cortivis Pipeline Products & Ongoing Clinical Trials Overview
    Table 35: Cortical Visual Neuroprosthesis Implant - Product Status
    Table 36: Cortical Visual Neuroprosthesis Implant - Product Description
    Table 37: Cortivis - Ongoing Clinical Trials Overview
    Table 38: Cortical Visual Neuroprosthesis Implant - Pilot Study for the Development of a Cortical Visual Neuroprosthesis for the Blind Based on Intracortical Microelectrodes
    Table 39: Iowa State University Pipeline Products & Ongoing Clinical Trials Overview
    Table 40: Quadruple Butterfly Coil - Product Status
    Table 41: Quadruple Butterfly Coil - Product Description
    Table 42: King's College London Pipeline Products & Ongoing Clinical Trials Overview
    Table 43: rTMS System - Bulimia - Product Status
    Table 44: rTMS System - Bulimia - Product Description
    Table 45: Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview
    Table 46: GTEN 100 Neuromodulation Device - Product Status
    Table 47: GTEN 100 Neuromodulation Device - Product Description
    Table 48: Lawrence Livermore National Laboratory Pipeline Products & Ongoing Clinical Trials Overview
    Table 49: Implantable Neural Device - Product Status
    Table 50: Implantable Neural Device - Product Description
    Table 51: Neuronix Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 52: NeuroAD - Product Status
    Table 53: NeuroAD - Product Description
    Table 54: NeuroAD - MCI - Product Status
    Table 55: NeuroAD - MCI - Product Description
    Table 56: Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview
    Table 57: Navigated Brain Therapy System - Major Depressive Disorder - Product Status
    Table 58: Navigated Brain Therapy System - Major Depressive Disorder - Product Description
    Table 59: Navigated Brain Therapy System - Tinnitus - Product Status
    Table 60: Navigated Brain Therapy System - Tinnitus - Product Description
    Table 61: Wireless EMG Integrated NBS System - Product Status
    Table 62: Wireless EMG Integrated NBS System - Product Description
    Table 63: Nexstim Plc - Ongoing Clinical Trials Overview
    Table 64: Navigated Brain Therapy System - Major Depressive Disorder - Use of Nexstim SNBT System in Its Intended Use
    Table 65: NYU Langone Health System Pipeline Products & Ongoing Clinical Trials Overview
    Table 66: Brain Implant - Chronic Pain - Product Status
    Table 67: Brain Implant - Chronic Pain - Product Description
    Table 68: Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview
    Table 69: Microelectrode Array - Cortical Stimulation - Product Status
    Table 70: Microelectrode Array - Cortical Stimulation - Product Description
    Table 71: Precisis AG Pipeline Products & Ongoing Clinical Trials Overview
    Table 72: EASEE System - Product Status
    Table 73: EASEE System - Product Description
    Table 74: Precisis AG - Ongoing Clinical Trials Overview
    Table 75: EASEE System - EASEE4YOU – A Clinical Investigation of the Safety and Efficacy of Transcranial Focal Cortex Stimulation with the EASEE System for the Treatment of Medically Refractory Focal Epilepsy in Young Patients, Aged 12 to 17 Years
    Table 76: Ripple Pipeline Products & Ongoing Clinical Trials Overview
    Table 77: Wireless EcoG Device - Product Status
    Table 78: Wireless EcoG Device - Product Description
    Table 79: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
    Table 80: Renova-DT Cortical Stimulation System - Product Status
    Table 81: Renova-DT Cortical Stimulation System - Product Description
    Table 82: Renova-ST Cortical Stimulation System - Product Status
    Table 83: Renova-ST Cortical Stimulation System - Product Description
    Table 84: Renova-TT Cortical Stimulation System - Product Status
    Table 85: Renova-TT Cortical Stimulation System - Product Description
    Table 86: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
    Table 87: Brain-Computer Microelectrode Interface - Product Status
    Table 88: Brain-Computer Microelectrode Interface - Product Description
    Table 89: WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
    Table 90: Cortical Grid - Product Status
    Table 91: Cortical Grid - Product Description
    Table 92: Glossary
    2.2 List of Figures
    Figure 1: Cortical Stimulators - Pipeline Products by Stage of Development
    Figure 2: Cortical Stimulators - Pipeline Products by Territory
    Figure 3: Cortical Stimulators - Pipeline Products by Regulatory Path
    Figure 4: Cortical Stimulators - Pipeline Products by Estimated Approval Date
    Figure 5: Cortical Stimulators - Ongoing Clinical Trials

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings